ImmunoGen, Inc. (IMGN)

NASDAQ: IMGN · IEX Real-Time Price · USD
5.31
+0.04 (0.76%)
At close: Aug 10, 2022 4:00 PM
5.16
-0.15 (-2.82%)
After-hours: Aug 10, 2022 5:48 PM EDT

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 2021202020192018201720162015201420132012 2011 - 1994
Revenue
69.86132.382.2753.45115.456085.5459.935.5416.36
Upgrade
Revenue Growth (YoY)
-47.20%60.81%53.93%-53.71%92.41%-29.86%42.82%68.55%117.25%-15.27%
Upgrade
Gross Profit
69.86132.382.2753.45115.456085.5459.935.5416.36
Upgrade
Selling, General & Admin
43.8138.638.4936.7533.9136.9228.2324.4721.4720.42
Upgrade
Research & Development
151.12114.59114.52174.46139.74148.08111.77106.9687.0769.19
Upgrade
Other Operating Expenses
01.4921.433.690.7800000
Upgrade
Operating Expenses
194.93154.68174.44214.9174.43184.99140131.43108.5489.61
Upgrade
Operating Income
-125.07-22.38-92.17-161.45-58.98-124.99-54.46-71.53-73.01-73.26
Upgrade
Interest Expense / Income
0.050.10.10.13.040.140000
Upgrade
Other Expense / Income
14.1821.911.877.333.9919.696.28-0.17-0.20.06
Upgrade
Pretax Income
-139.3-44.37-104.13-168.84-96.01-144.82-60.74-71.36-72.81-73.32
Upgrade
Net Income
-139.3-44.37-104.13-168.84-96.01-144.82-60.74-71.36-72.81-73.32
Upgrade
Net Income Common
-139.3-44.37-104.13-168.84-96.01-144.82-60.74-71.36-72.81-73.32
Upgrade
Shares Outstanding (Basic)
206176148140988786858477
Upgrade
Shares Outstanding (Diluted)
206176148140988786858477
Upgrade
Shares Change
17.03%18.77%5.98%42.70%12.75%1.09%0.65%1.69%9.44%11.46%
Upgrade
EPS (Basic)
-0.68-0.25-0.70-1.21-0.98-1.67-0.71-0.83-0.87-0.95
Upgrade
EPS (Diluted)
-0.68-0.25-0.70-1.21-0.98-1.67-0.71-0.83-0.87-0.95
Upgrade
Free Cash Flow Per Share
-0.83-0.44-0.60-1.230.07-1.55-0.73-0.72-0.76-0.48
Upgrade
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%
Upgrade
Operating Margin
-179.04%-16.92%-112.04%-302.08%-51.09%-208.31%-63.66%-119.42%-205.46%-447.86%
Upgrade
Profit Margin
-199.42%-33.54%-126.57%-315.91%-83.17%-241.35%-71.01%-119.15%-204.90%-448.24%
Upgrade
Free Cash Flow Margin
-244.57%-59.04%-108.06%-321.20%5.66%-224.75%-73.32%-103.24%-180.30%-227.40%
Upgrade
EBITDA
-137.24-42.18-100.01-161.34-87.01-139.35-55.23-66.77-68.17-68.69
Upgrade
EBITDA Margin
-196.46%-31.88%-121.56%-301.87%-75.37%-232.25%-64.56%-111.47%-191.84%-419.92%
Upgrade
Depreciation & Amortization
2.022.14.037.415.965.335.514.64.644.63
Upgrade
EBIT
-139.26-44.28-104.04-168.75-92.97-144.68-60.74-71.36-72.81-73.32
Upgrade
EBIT Margin
-199.35%-33.47%-126.46%-315.74%-80.53%-241.12%-71.01%-119.15%-204.90%-448.24%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).